Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | SCN1A | P35498 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27520237 | 0.87 | IDO1 (0.45) | TRPA1ATMCYP3A4TSHRRECQL | |
| SCHEMBL1827736 | 0.84 | CYP3A4 (0.43) | CYP3A4TSHRRECQLMAPTMAPK1 | |
| Bromide SCHEMBL1827609 | 0.82 | CYP3A4 (0.42) | CYP3A4TSHRRECQLMAPTMAPK1 | |
| SCHEMBL6884457 | 0.81 | TRPA1 (0.41) | TRPA1ATMCXCR2MAPTMAPK1 | |
| SCHEMBL1953525 | 0.79 | IDO1 (0.48) | CYP3A4TSHRRECQLMAPTMAPK1 | |
| SCHEMBL8762491 | 0.77 | CYP3A4 (0.47) | ATMCYP3A4TSHRRECQLMAPT | |
| SCHEMBL10814735 | 0.76 | TRPA1 (0.52) | TRPA1ATMCYP3A4TSHRRECQL | |
| SCHEMBL11663327 | 0.75 | MAPK14 (0.49) | CYP3A4TSHRRECQLMAPTGAA | |
| SCHEMBL13497804 | 0.75 | CD44 (0.46) | CYP3A4TSHRRECQLMAPTMAPK1 | |
| SCHEMBL11662307 | 0.75 | ALDH1A1 (0.44) | CYP3A4TSHRRECQLMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016012333-A1 | PESTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-01-28 | — | — | WO | disclosed |
| US-20090036437-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PHENOXAZINIUM COMPOUND AS AN ACTIVE INGREDIENT | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1852119-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PHENOXAZINIUM COMPOUND AS ACTIVE INGREDIENT | Japan Science and Technology Agency (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1442009-A1 | PRODUCTION OF KETO ACIDS | Ciba SC Holding AG (CH) | 2004-08-04 | — | — | EP | disclosed |
| WO-2003037846-A1 | PRODUCTION OF KETO ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-05-08 | — | — | WO | disclosed |
| US-4670451-A | Benzoxazolone-2 compounds and fungicidal use thereof | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-06-02 | — | — | US | disclosed |
| US-4353916-A | Benzothiazol-2-ones and phytopathogenic fungicidal use thereof | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1982-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036437-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PHENOXAZINIUM COMPOUND AS AN ACTIVE INGREDIENT | CYP3A5, IL5, HDAC5 | TRPA1 606/4885ATM 4829/4885CYP3A4 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.